This page lists the SEC filings reported by OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC).
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2021-02-16 | UBS OCONNOR LLC | GreenSky, Inc. | 6,953,855 | 9.1% | EDGAR |
| SC 13G | 2021-02-16 | UBS OCONNOR LLC | Amryt Pharma plc | 13,213,340 | 7.3% | EDGAR |
| SC 13G | 2021-02-16 | UBS OCONNOR LLC | Teligent, Inc. | 2,000,001 | 8.4% | EDGAR |
| SC 13G | 2021-02-16 | UBS OCONNOR LLC | ACORDA THERAPEUTICS INC | 5,323,234 | 10.0% | EDGAR |
| SC 13G/A | 2020-03-09 | UBS OCONNOR LLC | Protalix BioTherapeutics, Inc. | 941,176 | 6.0% | EDGAR |
| SC 13G/A | 2020-02-13 | UBS OCONNOR LLC | Protalix BioTherapeutics, Inc. | 8,000,000 | 5.1% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | New Providence Acquisition Corp. | 2,277,000 | 9.9% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | Acamar Partners Acquisition Corp. | 2,074,000 | 6.8% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | Act II Global Acquisition Corp. | 1,733,444 | 5.8% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | Amplitude Healthcare Acquisition Corp | 550,000 | 5.5% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | Apex Technology Acquisition Corp | 2,500,000 | 7.0% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | CHP Merger Corp. | 2,450,000 | 8.2% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | CIIG Merger Corp. | 1,800,000 | 7.0% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | DiamondPeak Holdings Corp. | 2,150,000 | 7.7% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | Experience Investment Corp. | 2,675,000 | 9.7% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | FinServ Acquisition Corp. | 1,800,000 | 7.0% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | GENOCEA BIOSCIENCES, INC. | 1,769,460 | 6.3% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | GigCapital2, Inc. | 1,158,400 | 5.2% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | GTY Technology Holdings Inc. | 3,200,000 | 6.0% | EDGAR |
| SC 13G | 2020-02-13 | UBS OCONNOR LLC | Healthcare Merger Corp. | 1,600,000 | 6.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.